Who owns NEUROBO PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Neurobo Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Neurobo Pharmaceuticals stock

Who bought or sold NEUROBO PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Geode Capital Management 139k $66k 100% Sep 2023
 View chart
BlackRock 42k $20k 0% Sep 2023
 View chart
State Street Corporation 23k $11k 100% Sep 2023
 View chart
Tower Research Capital 12k $5.9k 12% Sep 2023
 View chart
Brian McDonald 22.00 $9.999000 100% Sep 2023
 View chart
Morgan Stanley 2.00 $1.000000 0% Sep 2023
 View chart

Who sold out of Neurobo Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Vanguard Group Sep 2023 70k $33k
Citadel Advisors Sep 2023 46k $22k
Two Sigma Securities Sep 2023 43k $21k
Virtu Financial Sep 2023 32k $15k
Wells Fargo & Company Sep 2023 188.00 $88.999200
UBS Group Sep 2023 142.00 $68.003800
Bank of America Corporation Sep 2023 8.00 $4.000000